Interestingly, in most cases, EME1 expression did not correlate with increased/decreased patient survival, except in the case of BRCA1-deficient breast cancer, where low EME1 expression associated with a favourable prognosis (Fig. S7G–J), although these two factors had partially separable impacts on survival (Fig. S7K). Here, EME1 is linked to breast cancer.